Tocilizumab in the treatment of myocardial infarction

Acute Myocardial Infarction

(2017) Jeffrey L. Anderson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Short-term application of tocilizumab during myocardial infarction (STAT-MI)

(2017) Matthew B. Carroll et al.   RHEUMATOLOGY INTERNATIONAL

Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-ST-elevation myocardial infarction: a double-blind, randomized, placebo-controlled phase 2 trial

(2016) Ola Kleveland et al.   EUROPEAN HEART JOURNAL

TAFRO syndrome successfully treated with tocilizumab: A case report and systematic review

(2016) Kazuya Sakai et al.   Modern Rheumatology

Circulating Levels of IL‐6 Receptor and gp130 and Long‐Term Clinical Outcomes in ST‐Elevation Myocardial Infarction

(2016) Vibeke N. Ritschel et al.   Journal of the American Heart Association

Inhibition of Interleukin-6 Receptor in a Murine Model of Myocardial Ischemia-Reperfusion

(2016) Minke H. T. Hartman et al.   PLoS One

Discovery of Innovative Therapies for Rare Immune-Mediated Inflammatory Diseases via Off-Label Prescription of Biologics: The Case of IL-6 Receptor Blockade in Castleman’s Disease

(2015) Anne Musters et al.   Frontiers in Immunology

Short-term efficacy of the IL6 receptor antibody tocilizumab in patients with HIV-associated multicentric Castleman disease: report of two cases

(2014) Azusa Nagao et al.   Journal of Hematology & Oncology

2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes

(2014) Ezra A. Amsterdam et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Inflammatory Biomarkers, Death, and Recurrent Nonfatal Coronary Events After an Acute Coronary Syndrome in the MIRACL Study

(2013) Payman Zamani et al.   Journal of the American Heart Association

The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis

(2012)   LANCET

Interleucina 6 y proteína C reactiva ultrasensible para la predicción de la evolución clínica en síndromes coronarios agudos sin elevación del segmento ST

(2012) Ángel López-Cuenca et al.   REVISTA ESPANOLA DE CARDIOLOGIA

Peri-procedural myocardial injury during percutaneous coronary intervention: an important target for cardioprotection

(2010) G. Ganesha Babu et al.   EUROPEAN HEART JOURNAL